Article Text

Download PDFPDF
Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction
  1. D Rimar1,
  2. E Crystal1,
  3. A Battler3,
  4. S Gottlieb2,
  5. D Freimark2,
  6. H Hod2,
  7. V Boyko2,
  8. L Mandelzweig2,
  9. S Behar2,
  10. J Leor2
  1. 1Cardiology Department, Soroka Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
  2. 2Neufeld Cardiac Research Institute, Tel Aviv University, Sheba Medical Center, Tel-Hashomer, Israel
  3. 3Cardiology Department, Rabin Medical Center, Petach-Tikva, Israel
  1. Correspondence to:
    Dr J Leor, Neufeld Cardiac Research Institute, Sheba Medical Center, Tel-Hashomer 52621, Israel;


Objective: To describe the clinical features, management, and prognosis of patients presenting with clinical markers of spontaneous reperfusion (SR) during acute myocardial infarction (AMI).

Design: Cohort study.

Setting: National registry of 26 coronary care units.

Patients: 2382 consecutive patients with AMI.

Main outcome measures: Patient characteristics, management, and mortality.

Results: The incidence of SR was 4% of patients (n = 98) compared with thrombolytic treatment (n = 1163, 49%), primary angioplasty (n = 102, 4%), and non-reperfusion (n = 1019, 43%). SR patients were more likely to develop less or no myocardial damage as indicated by a higher percentage of non-Q wave AMI (58% v 32%, 47%, and 44%, respectively, p < 0.0001), aborted AMI (25% v 9%, 8%, and 12%, p < 0.001), and lower peak creatine kinase (503 v 1384, 1519, and 751 IU, p < 0.0001). SR patients, however, were more likely to develop recurrent ischaemic events (35% v 17%, 12%, and 16%, respectively; p < 0.001) and subsequently were more likely to be referred to coronary angiography (67%), angioplasty (41%), or bypass surgery (16%, p < 0.001). Mortality at 30 days (1% v 8%, 7%, and 13%, respectively, p < 0.0001) and one year (6% v 11%, 12%, and 19%, p < 0.0001) was significantly lower for SR patients than for the other subgroups. By multivariate analysis, SR remained a strong determinant of 30 day survival (odds ratio (OR) 0.16, 95% confidence interval (CI) 0.01 to 0.74). At one year, the association between SR and survival decreased (OR 0.49, 95% CI 0.18 to 1.13).

Conclusions: Clinical markers of SR are associated with greater myocardial salvage and favourable prognosis. The vulnerability of SR patients to recurrent ischaemic events suggests that they need close surveillance and may benefit from early intervention.

  • acute myocardial infarction
  • angina
  • reperfusion
  • thrombolysis
  • ACE, angiotensin converting enzyme
  • AMI, acute myocardial infarction
  • CABG, coronary artery bypass grafting
  • CK, creatine kinase
  • PAMI, primary angioplasty in myocardial infarction
  • PTCA, percutaneous coronary angioplasty
  • SR, spontaneous reperfusion
  • TIMI, thrombolysis in myocardial infarction

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.